Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone plus metformin before controlled ovarian stimulation in infertile women with diminished ovarian reserve
ChiCTR2000029341Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Feb 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of somatropin and metformin in infertility and Diminished Ovarian Reserve (DOR) (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Pregnancy rate and Good-quality embryo rate. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
somatropinmetformin
03
Conditions
infertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on ChiCTR2000029341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029341.